．

Material Information - The Company Announces Submission of Marketing Authorization Application of Ropeginterferon alfa-2b (P1101) for ET in China

Jun 30, 2025

20250630 本公司新藥Ropeginterferon alfa-2b申請中國上市許可證，適應症為ET (EN).pdf

Download